<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-263GUYGV</identifier><date>2022</date><creator>Avsec, Damjan</creator><creator>Markovič, Tijana</creator><creator>Mlinarič-Raščan, Irena</creator><creator>Podgornik, Helena</creator><creator>Šmid, Alenka</creator><relation>documents/doc/2/URN_NBN_SI_doc-263GUYGV_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-263GUYGV_001.txt</relation><format format_type="issue">4</format><format format_type="type">article</format><format format_type="extent">str. 137</format><identifier identifier_type="COBISSID_HOST">122187267</identifier><identifier identifier_type="ISSN">2670-4463</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-263GUYGV</identifier><language>eng</language><publisher publisher_location="Ljubljana">Slovensko združenje za klinično kemijo in laboratorijsko medicino</publisher><source>Laboratorijska medicina</source><rights>InC</rights><subject language_type_id="slv">biomarkerji</subject><subject language_type_id="slv">Kronična limfocitna levkemija</subject><subject language_type_id="slv">prostaglandin EP4 receptor</subject><title>Prostaglandinski receptor EP4 – nov potencialni biomarker in terapevtska tarča v kronični limfocitni levkemiji</title><title>Prostaglandin EP4 receptor as a potencial novel biomarker and therapeutic target in chronic lymphocytic leukemia</title></Record>